ES2096574T3 - Procedimiento para la preparacion enantioselectiva de (omega-1)-hidroxialquilxantinas. - Google Patents
Procedimiento para la preparacion enantioselectiva de (omega-1)-hidroxialquilxantinas.Info
- Publication number
- ES2096574T3 ES2096574T3 ES90124746T ES90124746T ES2096574T3 ES 2096574 T3 ES2096574 T3 ES 2096574T3 ES 90124746 T ES90124746 T ES 90124746T ES 90124746 T ES90124746 T ES 90124746T ES 2096574 T3 ES2096574 T3 ES 2096574T3
- Authority
- ES
- Spain
- Prior art keywords
- hidroxialquilxantinas
- enantioselectiva
- omega
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/002—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
SE SELECCIONA UNA FAMILIA RHODOTORULA RUBRA QUE REDUCE EN UN 100% A LA PENTOXIFILINA EN ALCOHOL-S; SE TRANSFORMA OTRO DERIVADO OXOALQUILOXANTRINO EN ALCOHOL -S; EL ENANTIONATO S-(+) OBTENIDO MICROBIOLOGICAMENTE PUEDE TRANSFORMARSE ESTEREOSELECTIVAMENTE EN EL ENANTIOMERO R-(-) Y EL ALCOHOL -S Y EL ALCOHOL + R OBTENIDO POR INVERSION DE LA CONFIGURACION ENANTIOSELECTIVA, COOPERAN PARA CONCENTRAR EL RIEGO SANGUINEO DEL HIGADO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3942872A DE3942872A1 (de) | 1989-12-23 | 1989-12-23 | Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2096574T3 true ES2096574T3 (es) | 1997-03-16 |
Family
ID=6396381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90124746T Expired - Lifetime ES2096574T3 (es) | 1989-12-23 | 1990-12-19 | Procedimiento para la preparacion enantioselectiva de (omega-1)-hidroxialquilxantinas. |
Country Status (9)
Country | Link |
---|---|
US (3) | US5310666A (es) |
EP (1) | EP0435152B1 (es) |
JP (1) | JP2726760B2 (es) |
KR (1) | KR0174542B1 (es) |
AT (1) | ATE145247T1 (es) |
DE (2) | DE3942872A1 (es) |
DK (1) | DK0435152T3 (es) |
ES (1) | ES2096574T3 (es) |
GR (1) | GR3021611T3 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3942871A1 (de) * | 1989-12-23 | 1991-06-27 | Hoechst Ag | R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel |
US5580874A (en) * | 1992-03-04 | 1996-12-03 | Cell Therapeutics, Inc. | Enatiomerically pure hydroxylated xanthine compounds |
US5648357A (en) * | 1992-03-04 | 1997-07-15 | Cell Therapeutics, Inc. | Enatiomerically pure hydroxylated xanthine compounds |
AU669702B2 (en) * | 1992-03-04 | 1996-06-20 | Cell Therapeutics, Inc. | Enantiomeric hydroxylated xanthine compounds |
EP0570831A2 (de) * | 1992-05-20 | 1993-11-24 | Hoechst Aktiengesellschaft | Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation |
AU5957694A (en) * | 1992-12-31 | 1994-08-15 | Immulogic Pharmaceutical Corporation | Allergenic proteins and peptides from dog dander and uses therefor |
AU6092794A (en) * | 1993-01-19 | 1994-08-15 | Cell Therapeutics, Inc. | Oxime-substituted therapeutic compounds |
DE69528585D1 (de) * | 1994-05-16 | 2002-11-21 | Cell Therapeutics Inc | Asymmetrische synthese von chiralen sekondären alkoholen |
US20040110776A1 (en) * | 2002-02-22 | 2004-06-10 | Iok-Hou Pang | Use of propentofylline to control intraocular pressure |
EP1791965A1 (en) * | 2004-08-26 | 2007-06-06 | Pfizer, Inc. | Enantioselective biotransformation for preparation of protein tyrosine kinase inhibitor intermediates |
EP2265334A2 (en) | 2008-02-29 | 2010-12-29 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
US20110053961A1 (en) | 2009-02-27 | 2011-03-03 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
US8263601B2 (en) | 2009-02-27 | 2012-09-11 | Concert Pharmaceuticals, Inc. | Deuterium substituted xanthine derivatives |
IN2012DN01642A (es) | 2009-09-02 | 2015-06-05 | Concert Pharmaceuticals Inc | |
WO2012031073A1 (en) | 2010-09-01 | 2012-03-08 | Concert Pharmaceuticals, Inc. | Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation |
WO2012031072A1 (en) * | 2010-09-01 | 2012-03-08 | Concert Pharmaceuticals, Inc. | Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation |
RU2740926C1 (ru) * | 2020-09-02 | 2021-01-21 | федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Производные тиетансодержащих 1-бутил-3-метилксантинов, проявляющие антиоксидантную активность |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE23032C (de) * | DAUCHE & P. DENIAUD in Nantes | Hebelpresse zum mechanischen Festdrücken des Bodens und Deckels von Konservenbüchsen auf die cylindrischen Mäntel derselben | ||
DE1233405B (de) * | 1964-09-05 | 1967-02-02 | Albert Ag Chem Werke | Verfahren zur Herstellung von 7-(Oxoalkyl)-1, 3-dimethylxanthinen |
DE1235320B (de) * | 1964-09-05 | 1967-03-02 | Albert Ag Chem Werke | Verfahren zur Herstellung von 1-(Oxoalkyl)-3, 7-dimethylxanthinen |
DE2330742C2 (de) * | 1973-06-16 | 1982-07-29 | Hoechst Ag, 6000 Frankfurt | 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
DE2462367A1 (de) * | 1974-01-22 | 1976-11-11 | Wuelfing J A Fa | 7-(oxoalkyl)-1,3-dialkylxanthine enthaltende arzneimittelzubereitungen |
DE2929596A1 (de) * | 1979-07-21 | 1981-02-05 | Hoechst Ag | Verfahren zur herstellung von oxoalkyl-xanthinen |
DE3525801A1 (de) * | 1985-07-19 | 1987-01-22 | Hoechst Ag | Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
DE8700523U1 (de) * | 1987-01-13 | 1987-05-07 | August Steinmeyer GmbH & Co KG, 72458 Albstadt | Kugelgewindetrieb |
-
1989
- 1989-12-23 DE DE3942872A patent/DE3942872A1/de not_active Withdrawn
-
1990
- 1990-12-19 AT AT90124746T patent/ATE145247T1/de not_active IP Right Cessation
- 1990-12-19 DE DE59010566T patent/DE59010566D1/de not_active Expired - Fee Related
- 1990-12-19 EP EP90124746A patent/EP0435152B1/de not_active Expired - Lifetime
- 1990-12-19 DK DK90124746.0T patent/DK0435152T3/da active
- 1990-12-19 ES ES90124746T patent/ES2096574T3/es not_active Expired - Lifetime
- 1990-12-21 JP JP2418030A patent/JP2726760B2/ja not_active Expired - Lifetime
- 1990-12-21 KR KR1019900021299A patent/KR0174542B1/ko not_active IP Right Cessation
-
1992
- 1992-11-13 US US07/975,996 patent/US5310666A/en not_active Expired - Fee Related
-
1994
- 1994-02-10 US US08/194,563 patent/US5472873A/en not_active Expired - Fee Related
-
1995
- 1995-06-07 US US08/480,801 patent/US5710272A/en not_active Expired - Fee Related
-
1996
- 1996-11-14 GR GR960402906T patent/GR3021611T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0435152A3 (en) | 1992-08-05 |
JPH069633A (ja) | 1994-01-18 |
DK0435152T3 (da) | 1997-04-21 |
EP0435152A2 (de) | 1991-07-03 |
GR3021611T3 (en) | 1997-02-28 |
EP0435152B1 (de) | 1996-11-13 |
KR910012260A (ko) | 1991-08-07 |
ATE145247T1 (de) | 1996-11-15 |
US5710272A (en) | 1998-01-20 |
KR0174542B1 (ko) | 1999-02-01 |
JP2726760B2 (ja) | 1998-03-11 |
DE3942872A1 (de) | 1991-06-27 |
US5310666A (en) | 1994-05-10 |
DE59010566D1 (de) | 1996-12-19 |
US5472873A (en) | 1995-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2096574T3 (es) | Procedimiento para la preparacion enantioselectiva de (omega-1)-hidroxialquilxantinas. | |
AU8689591A (en) | High acid system nutritional formulations | |
FI873672A0 (fi) | Kompositioner innehaollande l-3,4-dihydroxifenylalanin. | |
ATE86297T1 (de) | Verfahren zur herstellung eines hefeextrakts. | |
DE3682208D1 (de) | Gegenueber lichteinfluss stabilisiertes nifedipin-konzentrat und verfahren zu seiner herstellung. | |
ATE148892T1 (de) | Absorbierende polymere, verfahren zu deren herstellung und deren verwendung | |
ES2031282T3 (es) | Separador para implantaciones dentales. | |
NZ212067A (en) | Derivatives of glycerophosphocholine and glycerophosphoethanolamine; preparation and use | |
SE8403567L (sv) | Fres | |
IT1248961B (it) | Supporto o ruota per autoveicoli | |
BR9404776A (pt) | Processo para a preparação de 2,2-difluorceteno silil acetais e processo para a preparação de ésteres de ácido alfa,alfa-diflúor-beta-sililóxi-1,3-dioxolano-4-propanóico | |
AU5629690A (en) | Carboplatin composition | |
DE3773045D1 (de) | Sockel fuer ein gebissmodell und verfahren zur herstellung eines gebissmodells. | |
AU1413788A (en) | Dihydropyridinamides process for their preparation, and their use in medicaments | |
AU4482985A (en) | Pyrro-1-yl-phenyl-dihydropyridazones | |
FR2526442B1 (fr) | Production de glucose deshydrogenase et utilisation de l'enzyme obtenu dans la synthese enzymatique de la l-carnitine | |
PT82020B (pt) | Processo para a preparacao de eter 4-(2-metoxietil)-fenilglicidilico e/ou metoprolol | |
IT1200100B (it) | Composizione a base di esteri parziali dell'acido fosforico, impiegabili per l'ingrasso in mezzo acquoso delle pelli conciate | |
DE3565535D1 (en) | Process for the preparation of optically active 1,4-dihydropyridines | |
IE890977L (en) | Isoxazolinones | |
AU2758288A (en) | Synergistic combination of decarboxylase inhibitors and l- dopa pellets | |
DE3882353D1 (de) | Hustenstillende zusammensetzungen und ein verfahren zu deren herstellung. | |
ATE40795T1 (de) | Verwendung eines zerebral und peripher wirkenden antihypoxidotikums. | |
AU7680187A (en) | Epoxy oligosaccharides | |
AU586557B2 (en) | 1,4-dihydropyridine derivatives, process for their preparation and medicaments containing these compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 435152 Country of ref document: ES |